Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination
Issue Cover
Current Issue
Volume 31,
Issue 6
1 June 2022
View This Issue

About the Journal

Cancer Epidemiology, Biomarkers & Prevention publishes articles featuring population-based research on cancer etiology, prevention, surveillance, survivorship, and cancer health disparities—with a particular focus on articles with a transdisciplinary approach. Read More About the Journal

Editors

Elizabeth A. Platz

View Full Editorial Board

Impact Factor

4.090

SUBMIT TO JOURNAL

Featured Articles

RESEARCH ARTICLE

Mapping the Lay of the Land: Using Interactive Network Analytic Tools for Collaboration in Rural Cancer Prevention and Control

Bobbi J. Carothers, et al.

RESEARCH ARTICLE

Quantifying differences in remaining life expectancy after cancer diagnosis, Aboriginal and Torres Strait Islanders and other Australians, 2005-2016

Paramita Dasgupta, et al.

Read the commentary on AACR Cancer Disparities Progress Report 2022

Patrick A. Williams, et al.

The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Gastric Cancer
Underutilization of Guideline-Recommended Mismatch Repair/Microsatellite Instability Biomarker Testing in Advanced Colorectal Cancer
Post-diagnostic Inflammatory, Hyperinsulinemic, and Insulin Resistant Diets and Lifestyles and the Risk of Prostate Cancer Progression and Mortality
Leveraging clinical trial populations and data from the Children's Oncology Group for cancer survivorship research
Persistent Disparities in Colorectal Cancer Screening: A Tell-Tale Sign for Implementing New Guidelines in Younger Adults
  • Online ISSN 1538-7755
  • Print ISSN 1055-9965

AACR Journals

 

 

  • Copyright © 2022 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept